|
1
|
Libby P: Inflammation in atherosclerosis.
Arterioscler Thromb Vasc Biol. 32:2045–2051. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Hansson GK and Hermansson A: The immune
system in atherosclerosis. Nat Immunol. 12:204–212. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimada K, Miyazaki T and Daida H:
Adiponectin and atherosclerotic disease. Clin Chim Acta. 344:1–12.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lima Freitas LC, Braga VA, do Socorro de
França Silva M, Cruz JC, Sousa Santos SH, de Oliveira Monteiro MM
and Balarini CM: Adipokines, diabetes and atherosclerosis: An
inflammatory association. Front Physiol. 6:3042015.PubMed/NCBI
|
|
5
|
Wang X, Chen Q, Pu H, Wei Q, Duan M, Zhang
C, Jiang T, Shou X, Zhang J and Yang Y: Adiponectin improves
NF-κB-mediated inflammation and abates atherosclerosis progression
in apolipoprotein E-deficient mice. Lipids Health Dis. 15:332016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chen YX, Zhang M, Cai Y, Zhao Q and Dai W:
The Sirt1 activator SRT1720 attenuates angiotensin II-induced
atherosclerosis in apoE-/− mice through inhibiting vascular
inflammatory response. Biochem Biophys Res Commun. 465:732–738.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobashi C, Urakaze M, Kishida M, Kibayashi
E, Kobayashi H, Kihara S, Funahashi T, Takata M, Temaru R, Sato A,
et al: Adiponectin inhibits endothelial synthesis of interleukin-8.
Circ Res. 97:1245–1252. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Michelsen KS, Wong MH, Shah PK, Zhang W,
Yano J, Doherty TM, Akira S, Rajavashisth TB and Arditi M: Lack of
Toll-like receptor 4 or myeloid differentiation factor 88 reduces
atherosclerosis and alters plaque phenotype in mice deficient in
apolipoprotein E. Proc Natl Acad Sci USA. 101:10679–10684. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gebhardt C, Németh J, Angel P and Hess J:
S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol.
72:1622–1631. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schiopu A and Cotoi OS: S100A8 and S100A9:
DAMPs at the crossroads between innate immunity, traditional risk
factors, and cardiovascular disease. Mediators Inflamm.
2013:8283542013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Altwegg LA, Neidhart M, Hersberger M,
Müller S, Eberli FR, Corti R, Roffi M, Sütsch G, Gay S, von
Eckardstein A, et al: Myeloid-related protein 8/14 complex is
released by monocytes and granulocytes at the site of coronary
occlusion: A novel, early, and sensitive marker of acute coronary
syndromes. Eur Heart J. 28:941–948. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ota H, Eto M, Ogawa S, Iijima K, Akishita
M and Ouchi Y: SIRT1/eNOS axis as a potential target against
vascular senescence, dysfunction and atherosclerosis. J Atheroscler
Thromb. 17:431–435. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brandes RP: Activating SIRT1: A new
strategy to prevent atherosclerosis? Cardiovasc Res. 80:163–164.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang QJ, Wang Z, Chen HZ, Zhou S, Zheng
W, Liu G, Wei YS, Cai H, Liu DP and Liang CC: Endothelium-specific
overexpression of class III deacetylase SIRT1 decreases
atherosclerosis in apolipoprotein E-deficient mice. Cardiovasc Res.
80:191–199. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Okauchi Y, Kishida K, Funahashi T, Noguchi
M, Ogawa T, Ryo M, Okita K, Iwahashi H, Imagawa A, Nakamura T, et
al: Changes in serum adiponectin concentrations correlate with
changes in BMI, waist circumference, and estimated visceral fat
area in middle-aged general population. Diabetes Care. 32:e1222009.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lim S, Quon MJ and Koh KK: Modulation of
adiponectin as a potential therapeutic strategy. Atherosclerosis.
233:721–728. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Korndörfer IP, Brueckner F and Skerra A:
The crystal structure of the human (S100A8/S100A9)2 heterotetramer,
calprotectin, illustrates how conformational changes of interacting
alpha-helices can determine specific association of two EF-hand
proteins. J Mol Biol. 370:887–898. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Donato R: Intracellular and extracellular
roles of S100 proteins. Microsc Res Tech. 60:540–551. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Viemann D, Strey A, Janning A, Jurk K,
Klimmek K, Vogl T, Hirono K, Ichida F, Foell D, Kehrel B, et al:
Myeloid-related proteins 8 and 14 induce a specific inflammatory
response in human microvascular endothelial cells. Blood.
105:2955–2962. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alexander RW: Theodore Cooper Memorial
Lecture. Hypertension and the pathogenesis of atherosclerosis.
Oxidative stress and the mediation of arterial inflammatory
response: A new perspective. Hypertension. 25:155–161. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bomfim GF, Dos Santos RA, Oliveira MA,
Giachini FR, Akamine EH, Tostes RC, Fortes ZB, Webb RC and Carvalho
MH: Toll-like receptor 4 contributes to blood pressure regulation
and vascular contraction in spontaneously hypertensive rats. Clin
Sci (Lond). 122:535–543. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Doyle AE and Fraser JR: Vascular
reactivity in hypertension. Circ Res. 9:755–761. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang A, Liu M, Liu X, Dong LQ, Glickman
RD, Slaga TJ, Zhou Z and Liu F: Up-regulation of adiponectin by
resveratrol: The essential roles of the Akt/FOXO1 and AMP-activated
protein kinase signaling pathways and DsbA-L. J Biol Chem.
286:60–66. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kao CL, Chen LK, Chang YL, Yung MC, Hsu
CC, Chen YC, Lo WL, Chen SJ, Ku HH and Hwang SJ: Resveratrol
protects human endothelium from H(2)O(2)-induced oxidative stress
and senescence via SirT1 activation. J Atheroscler Thromb.
17:970–979. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grześk G, Kozinski M, Tantry US, Wicinski
M, Fabiszak T, Navarese EP, Grzesk E, Jeong YH, Gurbel PA and
Kubica J: High-dose, but not low-dose, aspirin impairs
anticontractile effect of ticagrelor following ADP stimulation in
rat tail artery smooth muscle cells. Biomed Res Int.
2013:9282712013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Rivera L, Morón R, Zarzuelo A and Galisteo
M: Long-term resveratrol administration reduces metabolic
disturbances and lowers blood pressure in obese Zucker rats.
Biochem Pharmacol. 77:1053–1063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Grześk G, Wiciński M, Malinowski B, Grześk
E, Manysiak S, Odrowąż-Sypniewska G, Darvish N and Bierwagen M:
Calcium blockers inhibit cyclosporine A-induced hyperreactivity of
vascular smooth muscle cells. Mol Med Rep. 5:1469–1474.
2012.PubMed/NCBI
|
|
28
|
Itoh H and Hidaka H: Direct interaction of
calmodulin antagonists with Ca2+/calmodulin-dependent cyclic
nucleotide phosphodiesterase. J Biochem. 96:1721–1726. 1984.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Grześk E, Malinowski B, Wiciński M,
Szadujkis-Szadurska K, Sinjab TA, Manysiak S, Tejza B, Słupski M,
Odrowąż-Sypniewska G and Grześk G: Cyclosporine-A, but not
tacrolimus significantly increases reactivity of vascular smooth
muscle cells. Pharmacol Rep. 68:201–205. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Grześk E, Szadujkis-Szadurska K, Wiciński
M, Malinowski B, Sinjab TA, Tejza B, Pujanek M, Janiszewska E,
Kopczyńska A and Grześk G: Effect of
2,4,6-trimethyl-N-[3-(trifluoromethyl)phenyl]benzene-sulfonamide on
calcium influx in three contraction models. Biomedical Rep.
4:117–121. 2016.
|
|
31
|
Gupta SC, Tyagi AK, Deshmukh-Taskar P,
Hinojosa M, Prasad S and Aggarwal BB: Downregulation of tumor
necrosis factor and other proinflammatory biomarkers by
polyphenols. Arch Biochem Biophys. 559:91–99. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Tomé-Carneiro J, Gonzálvez M, Larrosa M,
Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, Tomás-Barberán FA,
García-Conesa MT and Espín JC: Resveratrol in primary and secondary
prevention of cardiovascular disease: A dietary and clinical
perspective. Ann N Y Acad Sci. 1290:37–51. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tomé-Carneiro J, Gonzálvez M, Larrosa M,
Yáñez-Gascón MJ, García-Almagro FJ, Ruiz-Ros JA, Tomás-Barberán FA,
García-Conesa MT and Espín JC: Grape resveratrol increases serum
adiponectin and downregulates inflammatory genes in peripheral
blood mononuclear cells: A triple-blind, placebo-controlled,
one-year clinical trial in patients with stable coronary artery
disease. Cardiovasc Drugs Ther. 27:37–48. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Militaru C, Donoiu I, Craciun A, Scorei
ID, Bulearca AM and Scorei RI: Oral resveratrol and calcium
fructoborate supplementation in subjects with stable angina
pectoris: Effects on lipid profiles, inflammation markers and
quality of life. Nutrition. 29:178–183. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Park SJ, Ahmad F, Philp A, Baar K,
Williams T, Luo H, Ke H, Rehmann H, Taussig R, Brown AL, et al:
Resveratrol ameliorates aging-related metabolic phenotypes by
inhibiting cAMP phosphodiesterases. Cell. 148:421–433. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kline LW and Karpinski E: The
Resveratrol-induced Relaxation of Cholecystokinin Octapeptide- or
KCl-induced Tension in Male Guinea Pig Gallbladder Strips Is
Mediated Through L-type Ca2+Channels. J Neurogastroenterol Motil.
21:62–68. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Evgenov OV, Busch CJ, Evgenov NV, Liu R,
Petersen B, Falkowski GE, Petho B, Vas A, Bloch KD, Zapol WM and
Ichinose F: Inhibition of phosphodiesterase 1 augments the
pulmonary vasodilator response to inhaled nitric oxide in awake
lambs with acute pulmonary hypertension. Am J Physiol Lung Cell Mol
Physiol. 290:L723–L729. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Giachini FR, Lima VV, Carneiro FS, Tostes
RC and Webb RC: Decreased cGMP level contributes to increased
contraction in arteries from hypertensive rats: Role of
phosphodiesterase 1. Hypertension. 57:655–663. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Rybalkin SD, Rybalkina I, Beavo JA and
Bornfeldt KE: Cyclic nucleotide phosphodiesterase 1C promotes human
arterial smooth muscle cell proliferation. Circ Res. 90:151–157.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Bischoff E: Potency, selectivity, and
consequences of nonselectivity of PDE inhibition. Int J Impot Res.
16:(Suppl 1). S11–S14. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Thompson AM, Martin KA and Rzucidlo EM:
Resveratrol induces vascular smooth muscle cell differentiation
through stimulation of SirT1 and AMPK. PLoS One. 9:e854952014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Stein S, Schäfer N, Breitenstein A, Besler
C, Winnik S, Lohmann C, Heinrich K, Brokopp CE, Handschin C,
Landmesser U, et al: SIRT1 reduces endothelial activation without
affecting vascular function in ApoE-/− mice. Aging (Albany NY).
2:353–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Miyazaki R, Ichiki T, Hashimoto T, Inanaga
K, Imayama I, Sadoshima J and Sunagawa K: SIRT1, a longevity gene,
downregulates angiotensin II type 1 receptor expression in vascular
smooth muscle cells. Arterioscler Thromb Vasc Biol. 28:1263–1239.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Higashida K, Kim SH, Jung SR, Asaka M,
Holloszy JO and Han DH: Effects of resveratrol and SIRT1 on PGC-1α
activity and mitochondrial biogenesis: A reevaluation. PLoS Biol.
11:e10016032013. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Li J, Feng L, Xing Y, Wang Y, Du L, Xu C,
Cao J, Wang Q, Fan S, Liu Q and Fan F: Radioprotective and
antioxidant effect of resveratrol in hippocampus by activating
Sirt1. Int J Mol Sci. 15:5928–5939. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Cantó C, Gerhart-Hines Z, Feige JN,
Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P and Auwerx
J: AMPK regulates energy expenditure by modulating NAD+ metabolism
and SIRT1 activity. Nature. 458:1056–1060. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Beaudoin MS, Snook LA, Arkell AM, Simpson
JA, Holloway GP and Wright DC: Resveratrol supplementation improves
white adipose tissue function in a depot-specific manner in Zucker
diabetic fatty rats. Am J Physiol Regul Integr Comp Physiol.
305:R542–R551. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Gómez-Zorita S, Fernández-Quintela A, Lasa
A, Hijona E, Bujanda L and Portillo MP: Effects of resveratrol on
obesity-related inflammation markers in adipose tissue of
genetically obese rats. Nutrition. 29:1374–1380. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Palsamy P and Subramanian S: Resveratrol
protects diabetic kidney by attenuating hyperglycemia-mediated
oxidative stress and renal inflammatory cytokines via Nrf2-Keap1
signaling. Biochim Biophys Acta. 1812:719–731. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cdos Costa S, Rohden F, Hammes TO, Margis
R, Bortolotto JW, Padoin AV, Mottin CC and Guaragna RM: Resveratrol
upregulated SIRT1, FOXO1, and adiponectin and downregulated
PPARγ1-3 mRNA expression in human visceral adipocytes. Obes Surg.
21:356–361. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Newton RA and Hogg N: The human S100
protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on
neutrophils. J Immunol. 160:1427–1435. 1998.PubMed/NCBI
|
|
52
|
Kim MH, Yoo DS, Lee SY, Byeon SE, Lee YG,
Min T, Rho HS, Rhee MH, Lee J and Cho JY: The TRIF/TBK1/IRF-3
activation pathway is the primary inhibitory target of resveratrol,
contributing to its broad-spectrum anti-inflammatory effects.
Pharmazie. 66:293–300. 2011.PubMed/NCBI
|
|
53
|
Sunahori K, Yamamura M, Yamana J, Takasugi
K, Kawashima M, Yamamoto H, Chazin WJ, Nakatani Y, Yui S and Makino
H: The S100A8/A9 heterodimer amplifies proinflammatory cytokine
production by macrophages via activation of nuclear factor kappa B
and p38 mitogen-activated protein kinase in rheumatoid arthritis.
Arthritis Res Ther. 8:R692006. View
Article : Google Scholar : PubMed/NCBI
|
